fbpx
Inform | Inspire | Initiate

Patanjali didn’t mention Coronavirus while applying for license: Uttrakhand Official

1

After much of the controversy created by Baba Ramdev regarding his new Coronavirus Ayurvedic drug with 100% claims of its results, the Ministry of AYUSH has taken strict actions against Patanjali for concealing most important information while applying for the license. 

The Ministry of AYUSH has pulled up Patanjali Ayurved shortly after launching Coronil and asked it to stop advertising with no sales until the ministry verifies it. 

The state licensing authority (SLA) of Uttarakhand ready to take action on Haridwar-based Patanjali for launching Coronavirus medicine without approval from concerned authorities.

“Patanjali did not mention it was developing a drug for the coronavirus disease while applying for a license.” YS Rawat, License Officer of the Uttarakhand Ayurveda Department said.

Advertisements
Loading...

“As per the application, we issued them a license. They didn’t mention Coronavirus. We only approved the license for immunity booster, cough, and fever. In this regard, we will issue them a notice.” He added.

Now according to the Times of India report, Baba Ramdev has asked permission to test its Covid-19 treatment on patients in Indore earlier in the month of May only but the government put it in cold storage after the Indore administration showed it a red flag.

Indore’s MGM Medical College dean, Dr. Jyoti Bindal confirmed TOI that they had received a proposal from Patanjali in the respect of their new drug testing.

“I had forwarded it to officials in Bhopal to take the decision at their end. We haven’t yet received any reply.” He said.

Advertisements
Loading...

“To make a medicine a person has to go through the AYUSH ministry task force and send proper details of the research to the ministry for confirmation which Baba did not do at first. This is the rule and no one can advertise their products without it.” The minister of Ayush Mr. Shripad Naik was seen quoting in an interview with NDTV. 

[zombify_post]

Get real time updates directly on you device, subscribe now.

Subscribe to our newsletter
Sign up here to get the latest news, updates and special offers delivered directly to your inbox.
You can unsubscribe at any time
Loading...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More